Icon

SOHONOS - (1MG, 1.5MG, 2.5MG, 5MG, 10MG)

PALOVAROTENE None
1MG, 1.5MG, 2.5MG, 5MG, 10MG
Less Than $1000 mn
None None
None None
None None
SOHONOS is a retinoid indicated for reduction in the volume of new heterotopic ossification in adults and children aged 8 years and older for females and 10 years and older for males with fibrodysplasia ossificans progressiva (FOP).
Yes
SOHONOS Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.